Skip to main content

#154796

Anti-Tenascin [T2H5]

Cat. #154796

Anti-Tenascin [T2H5]

Cat. #: 154796

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Tenascin

Class: Monoclonal

Application: IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Netherlands Cancer Institute

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Tenascin [T2H5]
  • Research fields: Cell biology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 260 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; WB
  • Description: Tenascins are extracellular matrix glycoproteins. They are abundant in the extracellular matrix of developing vertebrate embryos and they reappear around healing wounds and in the stroma of some tumours.
  • Immunogen: Immunized with protein preparation from a homogenate of a human mammary tumor and mouse myeloma cells
  • Isotype: IgG1

Target Details

  • Target: Tenascin
  • Molecular weight: 260 kDa
  • Target background: Tenascins are extracellular matrix glycoproteins. They are abundant in the extracellular matrix of developing vertebrate embryos and they reappear around healing wounds and in the stroma of some tumours.

Applications

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Bosman et al. 1992. Prog Histochem Cytochem. 24(4):1-92. PMID: 1509094.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.